Insider Transactions in Q1 2023 at Albireo Pharma, Inc. (ALBO)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 02
2023
|
David Chiswell Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
56,278
-100.0%
|
-
|
|
Mar 02
2023
|
Simon N.R. Harford CFO and Treasurer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
13,739
-100.0%
|
-
|
|
Mar 02
2023
|
Pamela Stephenson Chief Commercial Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
22,242
-100.0%
|
-
|
|
Mar 02
2023
|
Ronald Harold Wilfred Cooper President and CEO |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
33,094
-100.0%
|
-
|
|
Mar 02
2023
|
Michelle Graham Chief Human Resources Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
5,543
-100.0%
|
-
|
|
Mar 02
2023
|
Martha J. Carter Chief Regulatory Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
3,656
-50.01%
|
-
|
|
Mar 02
2023
|
Jan Mattsson Chief Scientific Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
35,524
-100.0%
|
-
|
|
Mar 02
2023
|
Jason Duncan Chief Legal Officer and GC |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
3,296
-100.0%
|
-
|
|
Jan 23
2023
|
Ronald Harold Wilfred Cooper President and CEO |
SELL
Open market or private sale
|
Direct |
1,057
-1.81%
|
$45,451
$43.8 P/Share
|
|
Jan 23
2023
|
Jason Duncan Chief Legal Officer and GC |
SELL
Open market or private sale
|
Direct |
228
-1.59%
|
$9,804
$43.8 P/Share
|
|
Jan 23
2023
|
Simon N.R. Harford CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
102
-0.31%
|
$4,386
$43.8 P/Share
|
|
Jan 23
2023
|
Jan Mattsson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
197
-0.36%
|
$8,471
$43.8 P/Share
|
|
Jan 23
2023
|
Michelle Graham Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
102
-0.41%
|
$4,386
$43.8 P/Share
|
|
Jan 23
2023
|
Pamela Stephenson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
102
-0.24%
|
$4,386
$43.8 P/Share
|
|
Jan 23
2023
|
Martha J. Carter Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
120
-0.82%
|
$5,160
$43.8 P/Share
|
|
Jan 19
2023
|
Jason Duncan Chief Legal Officer and GC |
BUY
Grant, award, or other acquisition
|
Direct |
55,000
+44.3%
|
-
|
|
Jan 19
2023
|
Martha J. Carter Chief Regulatory Officer |
BUY
Grant, award, or other acquisition
|
Direct |
55,000
+44.17%
|
-
|
|
Jan 19
2023
|
Jan Mattsson Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
55,000
+33.44%
|
-
|
|
Jan 19
2023
|
Ronald Harold Wilfred Cooper President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
195,000
+43.58%
|
-
|
|
Jan 19
2023
|
Paul Streck Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
55,000
+31.62%
|
-
|
|
Jan 19
2023
|
Pamela Stephenson Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
55,000
+36.01%
|
-
|
|
Jan 19
2023
|
Simon N.R. Harford CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
55,000
+38.55%
|
-
|
|
Jan 19
2023
|
Michelle Graham Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,000
+36.16%
|
-
|
|
Jan 19
2023
|
Simon N.R. Harford CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
1,776
-5.14%
|
$76,368
$43.8 P/Share
|
|
Jan 19
2023
|
Michelle Graham Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
1,774
-6.73%
|
$76,282
$43.9 P/Share
|
|
Jan 19
2023
|
Jan Mattsson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,088
-5.35%
|
$132,784
$43.8 P/Share
|
|
Jan 19
2023
|
Pamela Stephenson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,774
-3.97%
|
$76,282
$43.9 P/Share
|
|
Jan 19
2023
|
Jason Duncan Chief Legal Officer and GC |
SELL
Open market or private sale
|
Direct |
938
-6.13%
|
$40,334
$43.9 P/Share
|
|
Jan 19
2023
|
Martha J. Carter Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
938
-6.03%
|
$40,334
$43.9 P/Share
|